Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

12.5K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
12.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The impact of recurrent urinary tract infections in women: a qualitative study.

The British journal of general practice : the journal of the Royal College of General Practitioners·2026
Same author

Economic Evaluation of Oral Nirmatrelvir-Ritonavir for COVID-19 in Higher Risk Outpatients.

JAMA network open·2026
Same author

Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC).

The Lancet. Microbe·2026
Same author

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.

The New England journal of medicine·2026
Same author

Brief Report: Association Between Pharmacologic Tenofovir Adherence Measures and Subsequent 24-Week Viral Load Outcomes for People With HIV in South Africa.

Journal of acquired immune deficiency syndromes (1999)·2026
Same author

Point-of-care HIV viral load testing in a community antiretroviral therapy delivery programme: A randomised controlled trial (PHILA).

PLOS global public health·2026

相关实验视频

Updated: Jun 10, 2025

A Standardized Procedure for Monitoring Harmful Algal Blooms in Chile by Metabarcoding Analysis
09:47

A Standardized Procedure for Monitoring Harmful Algal Blooms in Chile by Metabarcoding Analysis

Published on: August 26, 2021

5.1K

生物试验协议元数据注释:拟议的标准采用.

Rama Balakrishnan1, Ellen L Berg2, Christopher C Butler3

  • 1Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.

SLAS discovery : advancing life sciences R & D
|October 20, 2024
PubMed
概括

我们为制药药物发现试验开发了一种标准化元数据模板,以改善数据理解和计算分析. 该模板与自动注释工具相结合,可提高试验数据的公平性,以改善药物发现研究.

关键词:
检测注册检测的注册.生物测试是一种生物测试.数据标准 数据标准药物发现 药物发现这是公平的,公平的.这些元数据是元数据.存在论 (Ontology) 是一种存在论.协议 协议 协议 协议 协议

更多相关视频

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis
12:19

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis

Published on: April 22, 2022

3.8K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

相关实验视频

Last Updated: Jun 10, 2025

A Standardized Procedure for Monitoring Harmful Algal Blooms in Chile by Metabarcoding Analysis
09:47

A Standardized Procedure for Monitoring Harmful Algal Blooms in Chile by Metabarcoding Analysis

Published on: August 26, 2021

5.1K
Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis
12:19

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis

Published on: April 22, 2022

3.8K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

科学领域:

  • 生物医学研究生物医学研究
  • 药物发现 药物发现 药物发现
  • 数据科学数据科学数据科学

背景情况:

  • 生物测试对于推动生物医学研究和药物发现至关重要.
  • 随着测试数据数量的不断增加,对理解和比较提出了挑战.
  • 当前的测试数据往往缺乏标准化,阻碍了计算分析.

研究的目的:

  • 为制药药物发现试验引入标准化元数据模板.
  • 确保测试数据符合FAIR (可查找,可访问,可互操作,可重复使用) 原则.
  • 促进在药物发现中使用人工智能和计算方法.

主要方法:

  • 开发用于测试数据的标准化元数据模板.
  • 使用自动化工具来注释测试数据.
  • 整合来自各种来源的数据,如PubChem,商业供应商和文献.

主要成果:

  • 为药物发现试验创建了一个标准化的元数据模板.
  • 一个自动化工具有效地在模板中注释测试数据.
  • 该过程提高了来自多个来源的测试数据的公平性.

结论:

  • 标准化测试元数据增强了药物发现科学家的数据可比性和理解.
  • 改进的元数据促进了人工智能和计算工具用于分析和预测的应用.
  • 测试元数据的改进可以显著提高治疗和技术开发的生产力.